A new study has shown that adding sulfonylureas to first-line metformin treatment is likely a safer option than switching to sulfonylureas entirely in patients with type 2 diabetes. Consultant360 spoke with...
<p>In part 1 of this 4-part series, Dr Paul Mather from the Perelman School of Medicine talks about how to select and manage patients with end-stage heart failure.</p>
Bardia Nourbakhsh, MD, from Johns Hopkins University School of Medicine discusses the differences between progressive and relapsing multiple sclerosis.
Bardia Nourbakhsh, MD, from Johns Hopkins University School of Medicine discusses the different diagnosis tools for multiple sclerosis, as well as challenges in diagnosis.
Dr Hyman Scott from the UCSF-Glastone Center for AIDS Research discusses pre-exposure prophylaxis (PrEP) therapy, its indications, and clinical data surrounding its use.
<p>Dr Shaina Eckhouse from Washington School of Medicine in St. Louis talks about her session at the ASMBS Weekend 2018 and her research on reducing surgical site infections.</p>
<p>Margo Minissian,&nbsp;PhD, ACNP, from the Cedars-Sinai Heart Institute discusses her session about non-statin therapies for lowering cholesterol, which she will be presenting at Consultant's...
Newly published research indicates that red blood cell transfusions may be tied to the risk for venous thromboembolism. Recently, Consultant360 spoke with lead study author Ruchika Goel, MD, MPH, about the...
Andrew Meltzer, MD, from the George Washington University School of Medicine and Health Sciences, discusses his latest research, which suggests that tamsulosin may not be effective for certain ureteral...
